secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001493152-23-020735
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.08
LLM model:  deepseek-v4-flash:cloud@v2

MyMD Pharmaceuticals sets 2023 annual meeting for July 31, record date June 21, proposal deadline June 19
--------------------------------------------------------------------------------

- Annual Meeting to be held virtually on July 31, 2023.
- Record date for voting is June 21, 2023.
- Deadline for stockholder proposals under Rule 14a-8 is June 19, 2023.
- Director nominations and universal proxy notices also due by June 19, 2023.
- Meeting date changed by more than 30 days from 2022 anniversary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315223020735/0001493152-23-020735-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315223020735/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-020735

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer